Stability of hepatitis C virus RNA during specimen handling and storage prior to NASBA amplification

Journal of Virological Methods

Volumn 72, Issue 2, 1998, Pages 175-184

  Damen, M ^a   Sillekens, P ^b   Sjerps, M ^a   Melsert, R ^b   Frantzen, I ^b   Reesink, H W ^a   Lelie, P N ^a   Cuypers, H T M ^a  

^a CENTRAL LABORATORY   (Netherlands)

^b Organon Teknika   (Netherlands)

Author keywords

HCV RNA; Lysis buffer; NASBA QT; Stability; Storage conditions

Indexed keywords

VIRUS RNA;

ARTICLE; BLOOD SAMPLING; CALIBRATION; CONTROLLED STUDY; EXTRACTION; GENE AMPLIFICATION; GENOTYPE; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LABORATORY DIAGNOSIS; PRIORITY JOURNAL; RNA ANALYSIS; STORAGE; TECHNIQUE; TEMPERATURE;

BUFFERS; EDETIC ACID; GENE AMPLIFICATION; HEPACIVIRUS; HEPARIN; HUMANS; RNA, VIRAL; SPECIMEN HANDLING; TEMPERATURE; TIME FACTORS;

EID: 0031749873     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(98)00024-X     Document Type: Article

References (30)

1. Alberti A., Morsica G., Chemello L., Cavalletto D., Noventa F., Pontisso P., Ruol A. Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet. 340:1992;697-698.
2. Beutler E., Gelbart T., Kuhl W. Interference of heparin with polymerase chain reaction. Biotechniques. 90:1990;166-167.
3. Boom R., Sol C., Salimans M., Jansen C., Wertheim-van Dillen P., van der Noordaa J. A rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:1991;495-503.
4. Brouwer, J., Nevens, F., Kleter, B., Elewaut, A., Adler, M., Brenard, R., Chamuleau, R., Michielsen, P., Pirotte, J., Hautekeete, M., Weber, J., Bourgeois, N., Reesink, H., Geubel, A., Niesters, H., Hop, W., Hansen, B., ten Kate, F., Bronkhorst, C., Heijtink, R., Fevery, J., Schalm, S., 1998. Efficacy of IFN dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients. J. Hepatol. (in press).
5. Bruisten S., Oudshoorn P., van Swieten P., Boeser-Nunnink B., van Aarle P., Tondreau S., Cuypers H. Stability of HIV-1 RNA in blood during specimen handling and storage prior to amplification by NASBA-QT. J. Virol. Methods. 67:1997;199-207.
6. Busch M., Wilber J., Johnson P., Tobler L., Evans C. Impact of specimen handling and storage on detection of hepatitis C virus RNA. Transfusion. 32:1992;420-425.
7. Cheung R., Matsui S., Greenberg H. Rapid and sensitive method for detection of hepatitis C virus RNA by using silica particles. J. Clin. Microbiol. 32:1994;2593-2597.
8. Cuypers, H., Bresters, D., Winkel, I., Reesink, H., Weiner, A., Houghton, M., van der Poel, C., Lelie, P., 1992. Storage conditions of blood samples and primer selection affect the yield of cDNA-polymerase chain reaction products of hepatitis C virus. J. Clin. Microbiol. 30, 3220-3224.
9. Davis G., Lau J., Urdea M., Neuwald P., Wilber J., Lindsay K., Perrillo R., Albrecht J. Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients. Hepatology. 19:1994;1337-1341.
10. Detmer J., Lagier R., Flynn J., Zayati C., Kolber J., Collins M., Urdea M., Sanchez-Pescador R. Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology. J. Clin. Microbiol. 34:1996;901-907.
11. van Gemen B., Kievits T., Romano J. Transcription based nucleic acid amplification methods like NASBA and 3SR applied to viral diagnosis. Rev. Med. Vir. 5:1995;205-211.
12. Halfon Ph., Khiri H., Gerolami V., Bourliere M., Feryn J., Reynier P., Gauthier A., Cartouzou G. Impact of various handling and storage conditions on quantitative detection of hepatitis C virus RNA. J. Hepatol. 25:1996;307-311.
13. Hawkins A., Davidson F., Simmonds P. Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2 and 3 by Quantiplex HCV-RNA assay versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution method. J. Clin. Microbiol. 35:1997;187-192.
14. Holodniy M., Kim S., Katzenstein D., Konrad M., Groves E., Merigan T. Inhibition of human immunodeficiency virus gene amplification by heparin. J. Clin. Microbiol. 29:1991;676-679.
15. Holodniy M., Mole L., Yen-Lieberman B., Margolis D., Starkey C., Carroll R., Spahlinger T., Todd J., Jackson J. Comparative stabilities of human immunodeficiency virus RNA in plasma from samples collected in VACUTAINER CPT, VACUTAINER PPT and standard VACUTAINER tubes. J. Clin. Microbiol. 33:1995;1562-1566.
16. Melsert, R., Damen, M., Cuypers, H., Boele, S., van Deursen, P., Ehren, R., Frantzen, I., Sillekens, P., Lens, P., 1997. Combined quantitation and genotyping of hepatitis C virus RNA using NASBA®. In: Hepatitis C Virus: Genetic Heterogeneity and Viral Load. GEMHEP, John Libbey Eurotext, Paris, pp. 79-88.
17. Miskovsky E., Carrella A., Gutekunst K., Sun Ch., Quinn T., Thomas D. Clinical characterisation of a competitive PCR assay for quantitative testing of hepatitis C virus. J. Clin. Microbiol. 34:1996;1975-1979.
18. Nalpas B., Romeo R., Pol S., Thiers V., Carnot F., Berthelot P., Brechot C. Serum hepatitis C virus (HCV) RNA: a reliable tool for evaluating HCV-related liver disease in anti-HCV-positive blood donors with persistently normal alanine aminotransferase values. Transfusion. 35:1995;750-753.
19. Prieto M., Olaso V., Verdu C., Cordoba J., Gisbert C., Rayon M., Carrasco D., Berenguer M., Higon M., Berenguer J. Does the healthy hepatitis C virus carrier state really exist? An analysis using polymerase chain reaction. Hepatology. 22:1995;413-417.
20. Quan C., Krajden M., Zhao J., Chan A. High-performance liquid chromatography to assess the effect of serum storage conditions on the detection of hepatitis C virus by the polymerase chain reaction. J. Virol. Methods. 43:1992;299-308.
21. Rumi M., Del Ninno E., Parravicini M., Romeo R., Soffredini R., Donato M., Wilber J., Russo A., Colombo M. A prospective, randomized trial comparing lymphoblastoid to recombinant interferon alpha 2a as therapy for chronic hepatitis C. Hepatology. 24:1996;1366-1370.
22. Satsangi J., Jewell D., Welsh K., Bunce M., Bell J. Effect of heparin on polymerase chain reaction. Lancet. 343:1994;1509-1510.
23. Schiffman M., Hofman C., Luketic V., Sanyal A., Contos M., Mills A. Improved sustained response following treatment of chronic hepatitis C by gradual reduction in the interferon dose. Hepatology. 24:1996;21-26.
24. Schuurman R., Descamps D., Weverling G., Kaye S., Tijnagel J., Williams I., van Leeuwen R., Tedder R., Boucher C., Brun-Vezinet F., Loveday C. Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 34:1996;3016-3022.
25. Todd J., Pachl C., White R., Yeghiazarian T., Johnson P., Taylor B., Holodney M., Kern D., Hamren S., Chernoff D., Urdea M. Performance characteristics for the quantitation of plasma HIV-1 RNA using branched-DNA signal amplification technology. J. Acq. Immune Def. Syndr. Human Retrovirol. 10(suppl 2):1995;S35-S44.
26. Vandamme A., Schmit J., van Dooren S., van Laethem K., Gobbers E., Kok W., Goubau P., Witvrouw M., Peetermans W., De Clerq E., Desmyter J. Quantification of HIV-1 RNA in plasma: comparable results with the NASBA HIV-1 RNA QT and the AMPLICOR HIV MONITOR test. J. Acq. Immune Def. Synd. 13:1996;127-139.
27. Wang J., Wang T., Sheu J., Lin S., Lin J., Chen D. Effects of anti-coagulants and storage of blood samples on efficacy of the polymerase chain reaction assay for hepatitis C virus. J. Clin. Microbiol. 30:1992;750-754.
28. Weiland O., Chen M., Lindh G., Mattsson L., Schvarcz R., Sönnerborg A., Wahl M., Wejstål R., Widell A., Norkrans G. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection. Scand. J. Infect. Dis. 27:1995;319-324.
29. Willems M., Moshage H., Nevens F., Fevery J., Yap S. Plasma collected from heparinized blood is not suitable for HCV-RNA detection by conventional RT-PCR assay. J. Virol. Methods. 42:1993;127-130.
30. Yuki N., Hayashi N., Kasahara A., Hagiwara H., Takehara T., Oshita M., Katayama K., Fusamoto H., Kamada T. Pretreatment viral load and response to prolonged interferon-alpha course for chronic hepatitis C. J. Hepatol. 22:1995;457-463.